Optimized use of TAF-LD(Tenofovir Alafenamide /Lamivudine/Dolutegravir(TAF-LD) among PLHIV In Kenya (1 CPD Credit)

The course provides updated knowledge and clinical decision-making skills on the expanded use of TAF-LD, as outlined in the Kenyan Most Recent Circular (2025) and supported by the WHO guidelines (2024).
Elijah Mungathia · November 25, 2025
+2041 enrolled
Not Enrolled

Course Includes

  • 7 Lessons
  • 3 Quizzes
  • Course Certificate